Table 3.

Executive dysfunctions whose risks were statistically-significant when the concentrations of the proteins listed on the left were in the top quartile.^a

	Early epoch				Late epoch
Proteins	W	I	S	E	W	I	S	E
CRP		Λ
SAA
MPO
IL-1β
IL-6
IL-6R
TNF-α	Λ		Λ	Λ
TNF-R1
TNF-R2
IL-8	Λ			Λ	Λ	Λ		Λ
RANTES
ICAM-1					Λ
VCAM-1
MMP-9
TSH			Λ
EPO	Λ
NT-4
BDNF							V	V
bFGF			V
IGF-1
IGFBP-1
VEGF
VEGF-R1			V			Λ	Λ
VEGF-R2
PIGF
Ang-1		V		V
Ang-2

^aThis table summarizes Appendix Tables 3, 5, 7 and 9, which deal with elevated concentrations on two days during the early epoch (first two postnatal weeks) and during the late epoch (third and fourth two postnatal weeks). Λ indicates increased risk of a Z-score < −1 on the assessment(s) identified at the top of each column, while V indicates decreased risk. W indicates a DAS-II Working Memory Z-score ≤ −1, I indicates a NEPSY-II Inhibitioninhibition Z- score ≤ −1, S indicates a NEPSY-II Inhibition-Switching Z- score ≤ −1, and E indicates the executive dysfunction composite defined as a Z-score ≤ −1 on all three assessments.